These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
639 related articles for article (PubMed ID: 15482650)
1. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation. Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives. Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives. Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of chalcone analogs as potential inhibitors of ADP- and collagen-induced platelet aggregation. Vijaya Bhaskar Reddy M; Tsai WJ; Qian K; Lee KH; Wu TS Bioorg Med Chem; 2011 Dec; 19(24):7711-9. PubMed ID: 22055718 [TBL] [Abstract][Full Text] [Related]
6. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization. Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624 [TBL] [Abstract][Full Text] [Related]
7. Effects of ethanol on pathways of platelet aggregation in vitro. Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075 [TBL] [Abstract][Full Text] [Related]
8. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation. Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038 [TBL] [Abstract][Full Text] [Related]
9. 2',5'-Dihydroxychalcone as a potent chemical mediator and cyclooxygenase inhibitor. Lin CN; Lee TH; Hsu MF; Wang JP; Ko FN; Teng CM J Pharm Pharmacol; 1997 May; 49(5):530-6. PubMed ID: 9178190 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity. Wang WY; Hsieh PW; Wu YC; Wu CC Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492 [TBL] [Abstract][Full Text] [Related]
11. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide. Rendu F; Bachelot C; Molle D; Caen J; Guez D J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063 [TBL] [Abstract][Full Text] [Related]
12. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity. Jin YR; Im JH; Park ES; Cho MR; Han XH; Lee JJ; Lim Y; Kim TJ; Yun YP J Cardiovasc Pharmacol; 2008 Jan; 51(1):45-54. PubMed ID: 18209568 [TBL] [Abstract][Full Text] [Related]
13. Antiplatelet activity of beta-carboline alkaloids from Perganum harmala: a possible mechanism through inhibiting PLCgamma2 phosphorylation. Im JH; Jin YR; Lee JJ; Yu JY; Han XH; Im SH; Hong JT; Yoo HS; Pyo MY; Yun YP Vascul Pharmacol; 2009; 50(5-6):147-52. PubMed ID: 19073282 [TBL] [Abstract][Full Text] [Related]
14. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation. Mori K; Kikuchi H; Obara Y; Iwashita M; Azumi Y; Kinugasa S; Inatomi S; Oshima Y; Nakahata N Phytomedicine; 2010 Dec; 17(14):1082-5. PubMed ID: 20637576 [TBL] [Abstract][Full Text] [Related]
16. Is epinephrine-induced platelet aggregation autoregulated by its metabolic degradation products in vivo? Evangelou AM; Malamas MP; Vezyraki P; Karkabounas SC In Vivo; 1998; 12(3):321-5. PubMed ID: 9706478 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of baicalein derivatives as potential anti-aggregatory and anti-inflammatory agents. Huang WH; Lee AR; Chien PY; Chou TC J Pharm Pharmacol; 2005 Feb; 57(2):219-25. PubMed ID: 15720786 [TBL] [Abstract][Full Text] [Related]
18. Antiplatelet activity of carnosic acid, a phenolic diterpene from Rosmarinus officinalis. Lee JJ; Jin YR; Lee JH; Yu JY; Han XH; Oh KW; Hong JT; Kim TJ; Yun YP Planta Med; 2007 Feb; 73(2):121-7. PubMed ID: 17410649 [TBL] [Abstract][Full Text] [Related]
19. YD-3, a novel inhibitor of protease-induced platelet activation. Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968 [TBL] [Abstract][Full Text] [Related]
20. 2'-Ethoxy-5'-methoxy-2-(5-methylthienyl)chalcone inhibits collagen-induced protein tyrosine phosphorylation and thromboxane formation during platelet aggregation and adhesion. Lo HM; Huang TF; Lin CN; Peng HC; Wu WB Pharmacology; 2009; 84(3):145-52. PubMed ID: 19690443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]